Clinical Indication

Thromboprophylaxis and treatment of DVT


Prescribe by brand name INHIXA® as different brands have different injection techniques.

Courses started during the dalteparin shortage can be continued to be supplied in primary care

Local guidance

Temporary ‘Conditional Green’ Traffic light status removed March 2019

Date of classification

March 2019


Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.